68 related articles for article (PubMed ID: 35750560)
21. Real-World Evaluation of Primary Versus Secondary Prevention of Skeletal-Related Events in Metastatic Castration-Resistant Prostate Cancer.
Phillips WJ; Saad F; Leigh J; Jooya A; Webber C; Morgan S; MacRae R; Bourque JM; Tanuseputro P; Ong M
Oncologist; 2024 Mar; ():. PubMed ID: 38527096
[TBL] [Abstract][Full Text] [Related]
22. Real-world treatment patterns and overall survival among men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) in the US Medicare population.
Freedland SJ; Davis M; Epstein AJ; Arondekar B; Ivanova JI
Prostate Cancer Prostatic Dis; 2024 Jun; 27(2):327-333. PubMed ID: 37783836
[TBL] [Abstract][Full Text] [Related]
23. Impact of Comorbidities and Drug Interactions in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Androgen Receptor Pathway Inhibitors.
Zhong YY; Anton A; Xie O; Tan N; O'Haire S; Maleki S; Inderjeeth AJ; Parente P; Spain L; Gibbs P; Tran B
JCO Oncol Pract; 2024 May; ():OP2400036. PubMed ID: 38805663
[TBL] [Abstract][Full Text] [Related]
24. Effects of metformin and silodosin as supplementary treatments to abiraterone on human telomerase reverse transcriptase (hTERT) level in metastatic castration-resistant prostate cancer (mCRPC) cells: An in vitro study.
Hidayatullah F; Andhika DP; Prasetyawan W; Rahman ZA; Pratama PK; Hakim L
Narra J; 2024 Apr; 4(1):e680. PubMed ID: 38798828
[TBL] [Abstract][Full Text] [Related]
25. Effects of In-office Dispensing by Single-specialty Urology Practices on Management of Advanced Prostate Cancer.
Lai LY; Kaufman SR; Oerline M; Caram MEV; Maganty A; Shahinian VB; Hollenbeck BK
Urol Pract; 2023 May; 10(3):230-235. PubMed ID: 37103497
[TBL] [Abstract][Full Text] [Related]
26. Determinants of Bone-Modifying Agent Prescribing for Metastatic Castration-Resistant Prostate Cancer in a National Health Care Delivery System.
Nguyen CB; Kobe C; Kumbier KE; Bauman J; Burns JA; Tsao PA; Sparks JB; Skolarus TA; Caram MEV
JCO Oncol Pract; 2024 Jan; 20(1):59-68. PubMed ID: 38085028
[TBL] [Abstract][Full Text] [Related]
27. Cost per patient and potential budget implications of denosumab compared with zoledronic acid in adults with bone metastases from solid tumours who are at risk of skeletal-related events: an analysis for Austria, Sweden and Switzerland.
Lothgren M; Ribnicsek E; Schmidt L; Habacher W; Lundkvist J; Pfeil AM; Biteeva I; Vrouchou P; Bracco A
Eur J Hosp Pharm; 2013 Aug; 20(4):227-231. PubMed ID: 23888248
[TBL] [Abstract][Full Text] [Related]
28. Skeletal-related events and mortality among men diagnosed with advanced prostate cancer: The impact of alternative measures of radiation to the bone.
Onukwugha E; Kwok Y; Ciezki JP; Yong C; Plaisant C; Reddy CA; Mullins CD; Seal B; Valderrama A; Hussain A
PLoS One; 2017; 12(4):e0175956. PubMed ID: 28419139
[TBL] [Abstract][Full Text] [Related]
29. Practical update for the use of bone-targeted agents in patients with bone metastases from metastatic breast cancer or castration-resistant prostate cancer.
Southcott D; Awan A; Ghate K; Clemons M; Fernandes R
Curr Oncol; 2020 Aug; 27(4):220-224. PubMed ID: 32905286
[TBL] [Abstract][Full Text] [Related]
30. Targeting bone metabolism in patients with advanced prostate cancer: current options and controversies.
Todenhöfer T; Stenzl A; Hofbauer LC; Rachner TD
Int J Endocrinol; 2015; 2015():838202. PubMed ID: 25802521
[TBL] [Abstract][Full Text] [Related]
31. Real-world treatment patterns and clinical outcomes in patients with prostate cancer.: A single institution experience in Saudi Arabia.
Khizanah RA; Tashkandi E; Jaffal M; Alsaedi M; Al-Ahmdi Y; Almehmadi A; Elnaghi KA
Saudi Med J; 2024 Jun; 45(6):639-642. PubMed ID: 38830651
[TBL] [Abstract][Full Text] [Related]
32. Current treatments and novel therapeutic targets for castration resistant prostate cancer with bone metastasis.
Wei J; Wang Z; Makarov D; Li X
Am J Clin Exp Urol; 2013; 1(1):30-8. PubMed ID: 25374898
[TBL] [Abstract][Full Text] [Related]
33. Major adverse cardiovascular events of enzalutamide versus abiraterone in prostate cancer: a retrospective cohort study.
Lee YHA; Hui JMH; Leung CH; Tsang CTW; Hui K; Tang P; Chan JSK; Dee EC; Ng K; McBride S; Nguyen PL; Tse G; Ng CF
Prostate Cancer Prostatic Dis; 2023 Dec; ():. PubMed ID: 38049634
[TBL] [Abstract][Full Text] [Related]
34. Factors associated with skeletal-related events in patients with bone metastatic melanoma: A retrospective study of 481 patients.
Shimizu MR; de Groot TM; Twining PK; Kobes T; Ferrone M; Raskin K; Jutte PC; Cohen S; Lozano-Calderon S; Groot OQ; Schwab JH
J Surg Oncol; 2024 Jun; ():. PubMed ID: 38881406
[TBL] [Abstract][Full Text] [Related]
35. Vertical integration of oncologists and cancer outcomes and costs in metastatic castration-resistant prostate cancer.
Hu X; Lipscomb J; Jiang C; Graetz I
J Natl Cancer Inst; 2023 Mar; 115(3):268-278. PubMed ID: 36583540
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and risk of skeletal complications and use of radiation therapy in elderly women diagnosed with metastatic breast cancer.
Hussain A; Yong C; Tkaczuk KHR; Qian Y; Arellano J; Mullins CD; Onukwugha E
PLoS One; 2018; 13(3):e0193661. PubMed ID: 29494653
[TBL] [Abstract][Full Text] [Related]
37. In-office dispensing of oral targeted agents by urology practices in men with advanced prostate cancer.
Hill D; Kaufman SR; Oerline MK; Faraj K; Caram MEV; Shahinian VB; Hollenbeck BK; Maganty A
JNCI Cancer Spectr; 2023 Jul; 7(5):. PubMed ID: 37643638
[TBL] [Abstract][Full Text] [Related]
38. Liaison Treatment for Metastatic Spinal Tumors.
Nakanishi K; Uchino K; Watanabe S; Iba H; Hasegawa T
Spine Surg Relat Res; 2020; 4(3):223-228. PubMed ID: 32864488
[TBL] [Abstract][Full Text] [Related]
39. Treatment Patterns, Clinical Outcomes, Health Care Resource Utilization and Costs in Older Patients With Metastatic Castration-Resistant Prostate Cancer in the United States: An Analysis of SEER-Medicare Data.
Swami U; Aggarwal H; Zhou M; Jiang S; Kim J; Li W; Laliberté F; Emond B; Agarwal N
Clin Genitourin Cancer; 2023 Oct; 21(5):517-529. PubMed ID: 37248148
[TBL] [Abstract][Full Text] [Related]
40. Improving Bone Health in Patients with Metastatic Prostate Cancer with the Use of Algorithm-Based Clinical Practice Tool.
Sahu KK; Johnson ED; Butler K; Li H; Boucher KM; Gupta S
Geriatrics (Basel); 2022 Nov; 7(6):. PubMed ID: 36547269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
